Long-Term Control of Hypercortisolism by Vandetanib in a Case of Medullary Thyroid Carcinoma with a Somatic RET Mutation-Reference-Cited by-同舟云学术

Long-Term Control of Hypercortisolism by Vandetanib in a Case of Medullary Thyroid Carcinoma with a Somatic RET Mutation

Published:2017-04 Issue:4 Volume:27 Page:587-590
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Paepegaey Anne-Cécile¹²,Cochand-Priollet Béatrix²³,Louiset Estelle⁴,Sarfati Pierre-Olivier⁵,Alifano Marco²⁶,Burnichon Nelly²⁷⁸,Bienvenu-Perrard Marie⁹,Lahlou Najiba²¹⁰,Bricaire Léopoldine¹,Groussin Lionel¹²

Affiliation:

1. Department of Endocrinology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

2. Université Paris Descartes, PRES Sorbonne Paris Cité, Faculté de Médecine, Paris, France.

3. Department of Pathology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

4. INSERM, Unité 982, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan, France; Institute for Research and Innovation in Biomedicine, Normandie Rouen University, Mont-Saint-Aignan, France.

5. Department of Digestive and Endocrine Surgery, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

6. Department of Thoracic Surgery, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

7. INSERM, UMR970, Paris-Cardiovascular Research Center, Paris, France.

8. Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Génétique, Paris, France.

9. Department of Nuclear Medicine, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

10. Department of Hormonal Biology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2016.0334

Reference10 articles.

1. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

2. Reversal of Cushing's Syndrome by Vandetanib in Medullary Thyroid Carcinoma

3. A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma

4. Vandetanib Successfully Controls Medullary Thyroid Cancer-Related Cushing Syndrome in an Adolescent Patient

5. Rapid response of hypercortisolism to vandetanib treatment in a patient with advanced medullary thyroid cancer and ectopic Cushing syndrome

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid and long-lasting response to selpercatinib of paraneoplastic Cushing’s syndrome in medullary thyroid carcinoma;European Thyroid Journal;2022-12-01

2. Medullary Thyroid Cancer with Ectopic Cushing's Syndrome: A Case Report and Systematic Review of Detailed Cases from the Literature;Thyroid;2022-11-01

3. Discovery of Pharmaceutical Composition for Prevention and Treatment in Patient-Derived Metastatic Medullary Thyroid Carcinoma Model;Biomedicines;2022-08-05

4. Metastatic medullary thyroid carcinoma: a new way forward;Endocrine-Related Cancer;2022-07-01

5. Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine;Frontiers in Endocrinology;2022-03-29